COMP <GO>
TBI vs ROMA // RSI-14 & 200D SMA MOMENTUM
TrueBlue Inc. (NYSE) VS. Roma Green Finance Limited (Class A) (NASDAQ) • 15-METRIC TALLY: TBI 5
— ROMA 2
▲ RSI-14 & 200D SMA MOMENTUM LEADER: TBI
LAST: $9.76 (+0.41%) • MKT CAP: $297.1M
rsi-technicals
60.9
LAST: $6.62 (-5.43%) • MKT CAP: $394.3M
rsi-technicals
40.6
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TBI VS. ROMA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TBI | ROMA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 22.80% | 17.10% | +5.70 | TBI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -11.70% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -24.81% | -0.65% | -24.16 | ROMA | /fcf-yield <GO> |
| Operating Margin | -2.90% | -60.00% | +57.10 | TBI | /operating-margins <GO> |
| Net Profit Margin | -3.00% | -60.00% | +57.00 | TBI | /net-margins <GO> |
| Revenue Growth (YoY) | — | -22.20% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.73 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 2/9 | +1.00 | TBI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 60.9 | 40.6 | +20.27 | TBI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $297.1M | $394.3M | -$97.2M | ROMA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TBI REV | ROMA REV | TBI GROSS % | ROMA GROSS % | TBI FCF | ROMA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.62B | $1.2M | 22.8% | 17.1% | -$73.7M | -$2.5M |
| FY 2024 | $1.57B | $1.6M | 25.9% | 37.0% | -$41.2M | -$1.6M |
| FY 2023 | $0 | $1.3M | — | — | $34.8M | -$3.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TBI // BETA —
ROMA // BETA —